- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
This is a Virtual Event for PsychU members in Maryland, Washington, DC, and Virginia.
Trace amines and trace amine-associated receptors (TAAR) are found throughout the brain and peripheral tissues and have modulating effects on neurotransmitters including dopamine, glutamate, and serotonin.1,2 The speaker(s) will discuss what are some of the potential effects of TAAR1 on neurotransmitter signaling related to schizophrenia and some of the preclinical data, as well as share the potential role of TAAR1 beyond schizophrenia.
Objectives:
- Summarize the Unmet Needs of Schizophrenia as it Relates to Neural Circuitry
- Introduction to Trace Amines (TA) and Trace Amine-Associated Receptors (TAARs) and Their Potential Relationship to Schizophrenia
- Discuss Potential Modulating Effects of TAAR1 on Neurotransmitter Signaling Associated with Schizophrenia Pathophysiology
Featuring
Dennis Sholler, PhD (OPDC)
Senior Medical Science Liaison, CNS
Speaker Dennis Sholler, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
-
Virtual Event – Care Coordination For Adult Patients With SMI – From Inpatient To Outpatient
May 22 12:00 pm to 1:00 pm
Registration
Related Resources
-
Comorbidities In Patients Living With Bipolar I Disorder
On-Demand Webinar March 28, 2024This moderated session explores common comorbidities, treatment options and the current guidelines for managing comorbid bipolar I patients.
-
What World Bipolar Day Means To Me Featuring Dr. Saklad
Interview March 27, 2024Please join us as Dr. Stephen Saklad shares his thoughts and perspectives on what bipolar day means to him.
-
What World Bipolar Day Means To Me Featuring Dr. Goldberg
Interview March 26, 2024Please join us as Dr. Joseph Goldberg shares his thoughts and perspectives on what bipolar day means to him.
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: